Ticker Details
Cytokinetics, Incorporated Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
IPO Date:	May 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 3.06%
Avg Daily Range (30 D):	$1.53 | 1.90%
Avg Daily Range (90 D):	$1.58 | 2.12%

Institutional Daily Volume
Avg Daily Volume:	.63M
Avg Daily Volume (30 D):	1.49M
Avg Daily Volume (90 D):	1.92M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	9,204
Avg Institutional Trade:	$3.59M
Avg Institutional Trade (30 D):	$5.78M
Avg Institutional Trade (90 D):	$5.54M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.3M
Avg Closing Trade (30 D):	$20.05M
Avg Closing Trade (90 D):	$25.67M
Avg Closing Volume:	187.09K

News

Aug 22, 2026 @ 9:22 PM Insider Transaction: Cytokinetics CEO Robert Blum ... Source: Jack Delaney

Jul 23, 2026 @ 8:00 PM Cytokinetics to Announce Second Quarter Results on... Source: Na

Jul 14, 2026 @ 9:20 PM What This Cytokinetics Insider Sale Might Mean Wit... Source: Jonathan Ponciano

Jun 17, 2026 @ 8:00 PM Cytokinetics Announces Inducement Grants Under Nas... Source: Na

May 27, 2026 @ 8:00 PM Cytokinetics to Participate in June Investor Confe... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-7.22	$-1.5	$-1.67
Diluted EPS	$-7.22	$-1.5	$-1.67
Revenue	$67.67M	$28.62M	$19.36M
Gross Profit
Net Income / Loss	$-894M	$-198.76M	$-206.03M
Operating Income / Loss	$-707.91M	$-179.17M	$-183.62M
Cost of Revenue
Net Cash Flow	$181.83M	$125.42M	$7.32M
PE Ratio

Splits
Jun 25, 2013	1:6